M. Broe

Most-cited papers

1. Clinicopathological correlates in frontotemporal dementia

   John R. Hodges, R. Davies, J. Xuereb, B. Casey +4 more

   2004Annals of Neurology576 citations Open access

   Semantic Scholar

   Save

2. Staging disease severity in pathologically confirmed cases of frontotemporal dementia

   M. Broe, J. Hodges, E. Schofield, C. Shepherd +2 more

   2003Neurology249 citations

   Semantic Scholar

   Save

3. Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin.

   B. Falini, L. Flenghi, F. Aversa, G. Barbabietola +11 more

   1992The Lancet219 citations

   Semantic Scholar

   Save

4. α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease

   G. M. Halliday, A. Ophof, M. Broe, P. Jensen +6 more

   2005197 citations Open access

   Semantic Scholar

   Save

5. Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease

   Jin-Xia Zhou, M. Broe, Yue Huang, John P. Anderson +7 more

   2011Acta Neuropathologica124 citations

   Semantic Scholar

   Save

6. Reactivities of 20 anti-human monoclonal antibodies with leucocytes from ten different animal species.

   C. Jacobsen, B. Aasted, M. Broe, J. L. Petersen

   1993Veterinary Immunology and Immunopathology115 citations

   Semantic Scholar

   Save

7. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia.

   M. Broe, J. Kril, G. Halliday

   2004Brain : a journal of neurology105 citations Open access

   Semantic Scholar

   Save

8. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

   G. Halliday, A. Ophof, M. Broe, P. Jensen +6 more

   2005Brain : a journal of neurology91 citations

   Semantic Scholar

   Save

9. In vivo targeting of Hodgkin and Reed‐Sternberg cells of Hodgkin's disease with monoclonal antibody Ber‐H2 (CD30): immimohistological evidence

   B. Falini, L. Flenghi, L. Fedeli, M. Broe +6 more

   1992British Journal of Haematology57 citations

   Semantic Scholar

   Save

10. Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies

    M. Broe, C. Shepherd, E. Milward, G. Halliday

    2001Acta Neuropathologica52 citations

    Semantic Scholar

    Save

11. Flow cytometric detection of EBV (EBER snRNA) using peptide nucleic acid probes.

    T. Just, Heidi Burgwald, M. Broe

    1998Journal of Virological Methods33 citations

    Semantic Scholar

    Save

12. Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies.

    J. Bonde, K. Meyer, M. Broe, M. Hokland +2 more

    1996British Journal of Haematology15 citations

    Semantic Scholar

    Save

13. Insoluble α-synuclein in alzheimer’s disease without lewy body formation

    M. Broe, C. Shepherd, D. Mann, E. Milward +3 more

    2009Neurotoxicity research9 citations

    Semantic Scholar

    Save

14. Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation.

    M. Broe, C. Shepherd, D. Mann, E. Milward +3 more

    2005Neurotoxicity research8 citations

    Semantic Scholar

    Save

15. The Effects of Field of View on Mental Models of Virtual Design Space

    Daniel Bourk, M. Broe, A. Jumani, Wai Yu +2 more

    20074 citations

    Semantic Scholar

    Save

16. In vivo targeting of Hodgkin's and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2. Immunoscintigrafic and immunohistological evidence.

    B. Falini, L. Flenghi, L. Fedeli, M. Broe +11 more

    19922 citations

    Semantic Scholar

    Save

17. Insoluble α-synuclein in the cortex of patients with Alzheimer's disease in the absence of Lewy body information.

    M. Broe, C. Shepherd, D. Mann, E. Milward +6 more

    20040 citations

    Semantic Scholar

    Save